Epinephrine Injection
Product Images NDC 0115-1695

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 0115-1695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Epinephrine Injection 1)

Chemical structure of epinephrine, showing a benzene ring with three hydroxyl groups, an attached side chain with a hydroxyl and an amine group.*

FDA Label Image

Case Label (0.15 mg)

Packaging label for epinephrine injection USP auto-injector 0.3 mg, manufactured by Amneal Pharmaceuticals of New York LLC. The label indicates a 2-pack and includes dosing instructions and safety warnings. The design features the Amneal logo and states the product is for subcutaneous injection.*

FDA Label Image

Carton (0.3 mg)

Epinephrine injection 0.3 mg auto-injector carton label by Amneal Pharmaceuticals of New York LLC. The label includes dosage strength 0.3 mg, instructions with illustrations for use, and storage information. It specifies the product is for intramuscular or subcutaneous use and includes regulatory and distributor details.*

FDA Label Image

Carrying Case 0.15 mg (Epinephrine Injection 2)

Illustration showing labeled components of an epinephrine auto-injector. Parts identified include carrying case, end caps, red tip (needle end), viewing window, and auto-injector body. The device shown contains 0.15 mg epinephrine dosage.*

FDA Label Image

Carry Case 0.3 mg (Epinephrine Injection 3)

An instructional illustration showing components of an epinephrine auto-injector containing 0.3 mg dosage. It labels the carrying case, end caps, red tip needle end, viewing window, and auto-injector body, highlighting the 0.3 mg strength on the label.*

FDA Label Image

Figure A (Epinephrine Injection 4)

An instructional illustration labeled Figure A showing a subcutaneous injection device for epinephrine. It depicts the step of pulling off both blue caps before use, with arrows indicating the pulling direction.*

FDA Label Image

Figure B (Epinephrine Injection 5)

An instructional illustration showing a hand administering a subcutaneous epinephrine injection by pushing the red tip firmly into the thigh for 10 seconds. The image emphasizes pressing the injection device into the outer thigh with an arrow indicating to push.*

FDA Label Image

Figure C (Epinephrine Injection 6)

Illustration showing hands removing the black cap from a subcutaneous injection device, exposing the needle. The image supports instructions for preparation or administration of the epinephrine injection by Amneal Pharmaceuticals of New York LLC.*

FDA Label Image

Figure D (Epinephrine Injection 7)

An instructional diagram labeled Figure D showing hands preparing an epinephrine subcutaneous injection. The illustration depicts the action of sliding or positioning the syringe, with an arrow indicating movement direction, likely as part of injection preparation or administration steps.*

FDA Label Image

Carton (0.15 mg)

Packaging label for epinephrine injection, USP auto-injector 0.15 mg by Amneal Pharmaceuticals of New York LLC. The label includes usage instructions with diagrams, dosage strength 0.15 mg, and storage information. The product is for subcutaneous injection and is indicated for allergic emergencies. The package contains two epinephrine auto-injectors and lists the NDC code 0115-1695-49.*

FDA Label Image

Wrap Label (0.15 mg)

Packaging label for epinephrine 0.15 mg auto-injector by Amneal Pharmaceuticals of New York LLC. The label includes dosing instructions with illustrations, safety warnings about usage, storage directions, and an authorization statement for the 0.15 mg strength. It specifies the product is for subcutaneous injection in allergic emergencies (anaphylaxis).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.